申请人:Eli Lilly and Company
公开号:US06436964B1
公开(公告)日:2002-08-20
The present invention provides the compounds of the following formula:
Wherein the variables are as defined in the specification and a method for inhibiting the reuptake of seretonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of the compound of above formula.
本发明提供了以下通式化合物:其中变量如说明书中所定义,以及抑制血清素再摄取、拮抗5-HT1A受体和拮抗5-HT2A受体的方法,该方法包括向需要此类治疗的对象施用上述通式的有效量的化合物。